Goldman Sachs Group Inc Repare Therapeutics Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.02 - $4.7 $48,676 - $75,754	-16,118 Reduced 44.42%	20,169 $66,000
Q1 2024 May 15, 2024	BUY	$4.53 - $8.41 $33,290 - $61,805	7,349 Added 25.4%	36,287 $170,000
Q4 2023 Feb 13, 2024	SELL	$3.22 - $11.79 $114,016 - $417,472	-35,409 Reduced 55.03%	28,938 $211,000
Q3 2023 May 14, 2024	BUY	$8.16 - $13.01 $288,937 - $460,671	35,409 Added 122.36%	64,347 $777,000
Q3 2023 Nov 14, 2023	SELL	$8.16 - $13.01 $5,475 - $8,729	-671 Reduced 1.03%	64,347 $777,000
Q2 2023 May 14, 2024	SELL	$8.63 - $12.53 $103,499 - $150,272	-11,993 Reduced 15.57%	65,018 $687,000
Q2 2023 Aug 14, 2023	SELL	$8.63 - $12.53 $103,499 - $150,272	-11,993 Reduced 15.57%	65,018 $687,000
Q1 2023 May 14, 2024	BUY	$9.32 - $15.06 $117,124 - $189,259	12,567 Added 19.5%	77,011 $757,000
Q1 2023 May 11, 2023	BUY	$9.32 - $15.06 $117,124 - $189,259	12,567 Added 19.5%	77,011 $757,000
Q4 2022 May 14, 2024	BUY	$12.5 - $18.13 $189,175 - $274,379	15,134 Added 30.69%	64,444 $947,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $18.13 $189,175 - $274,379	15,134 Added 30.69%	64,444 $947,000
Q3 2022 May 14, 2024	SELL	$11.57 - $15.59 $8,851 - $11,926	-765 Reduced 1.53%	49,310 $598,000
Q3 2022 Nov 10, 2022	SELL	$11.57 - $15.59 $8,851 - $11,926	-765 Reduced 1.53%	49,310 $598,000
Q2 2022 May 14, 2024	BUY	$8.45 - $14.84 $178,607 - $313,673	21,137 Added 73.04%	50,075 $700,000
Q2 2022 Aug 15, 2022	BUY	$8.45 - $14.84 $70,388 - $123,617	8,330 Added 19.95%	50,075 $700,000
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $121,185 - $233,000	10,649 Added 34.25%	41,745 $594,000
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $178,139 - $254,704	-9,061 Reduced 22.56%	31,096 $656,000
Q3 2021 Nov 10, 2021	BUY	$25.71 - $35.24 $1.03 Million - $1.42 Million	40,157 New	40,157 $1.05 Million

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

Bvf Inc San Francisco, CA

10.3M
Shares

$14 Million
1.13% of portfolio
Blue Owl Capital Holdings LP New York, NY

3.37M
Shares

$4.55 Million
3.82% of portfolio
Orbimed Advisors LLC San Diego, CA

3.32M
Shares

$4.49 Million
0.27% of portfolio
Chi Advisors LLC New York, NY

2.97M
Shares

$4.01 Million
17.66% of portfolio
Versant Venture Management, LLC San Francisco, CA

2.65M
Shares

$3.57 Million
23.86% of portfolio

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $56.6M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account